Table 6.
Immune related adverse effect.
Grade I | Grade II | |
---|---|---|
Cutaneous rash | 5 (45.5%) | 1 (9.1%) |
Fatigue | 3 (27.3%) | 0 |
Nausea | 1 (9.1%) | 0 |
Reactive cutaneouscapillary endothelial proliferation | 3 (27.3%) | 1 (9.1%) |
Anemia | 1 (9.1%) | 1 (9.1%) |
Liver malfunction | 2 (18.2%) | 0 |
Pruritus | 1 (9.1%) | 0 |